Literature DB >> 12674687

Deep vein thrombosis and systemic inflammatory response: a pilot trial.

Markus Reiter1, Robert A Bucek, Nihat Koca, Albert Dirisamer, Erich Minar.   

Abstract

INTRODUCTION: Symptoms of deep vein thrombosis as swelling, erythema, pain and calor have been suspected of being caused by an inflammatory reaction of the affected leg. We therefore performed a prospective pilot trial to study a possible systemic inflammatory response induced by deep vein thrombosis. PATIENTS AND METHODS: We determined white blood cell count and plasma C-reactive protein in 100 consecutive patients with suspected deep vein thrombosis. The final diagnosis was based on the results of duplex sonography or ascending venography.
RESULTS: Deep vein thrombosis was diagnosed in 37 patients (37%). White blood cell count (P = 0.012) and plasma C-reactive protein values (P < 0.001) were significantly increased in patients suffering from deep vein thrombosis. There was no correlation of white blood cell count or C-reactive protein with the thrombotic burden or the duration of symptoms.
CONCLUSION: In patients with deep vein thrombosis, thrombus formation and consequent vein wall damage induce a systemic inflammatory reaction which is reflected by significantly increased levels of white blood cells and plasma C-reactive protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674687     DOI: 10.1007/BF03040289

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  18 in total

Review 1.  Cellular and molecular mechanisms of inflammation and thrombosis.

Authors:  P Tan; F W Luscinskas; S Homer-Vanniasinkam
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-05       Impact factor: 7.069

2.  [Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis].

Authors:  B Jøssang; I Runde
Journal:  Tidsskr Nor Laegeforen       Date:  1992-03-30

3.  Serum C reactive protein does not reliably exclude lower limb deep venous thrombosis.

Authors:  N A Wong; R D Laitt; P R Goddard; J Virjee
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

4.  Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis.

Authors:  E A Thomas; M J Cobby; E Rhys Davies; W D Jeans; J T Whicher
Journal:  BMJ       Date:  1989-10-14

5.  Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis.

Authors:  L J Downing; T W Wakefield; R M Strieter; M R Prince; F J Londy; J B Fowlkes; M S Hulin; A M Kadell; C A Wilke; S L Brown; S K Wrobleski; M D Burdick; D C Anderson; L J Greenfield
Journal:  J Vasc Surg       Date:  1997-05       Impact factor: 4.268

6.  Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.

Authors:  T W Wakefield; R M Strieter; R Schaub; D D Myers; M R Prince; S K Wrobleski; F J Londy; A M Kadell; S L Brown; P K Henke; L J Greenfield
Journal:  J Vasc Surg       Date:  2000-02       Impact factor: 4.268

7.  Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation.

Authors:  L J Downing; R M Strieter; A M Kadell; C A Wilke; S L Brown; S K Wrobleski; M D Burdick; M S Hulin; J B Fowlkes; L J Greenfield; T W Wakefield
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

8.  IL-10 regulates thrombus-induced vein wall inflammation and thrombosis.

Authors:  L J Downing; R M Strieter; A M Kadell; C A Wilke; J C Austin; B D Hare; M D Burdick; L J Greenfield; T W Wakefield
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

9.  Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis.

Authors:  T W Wakefield; L J Greenfield; M W Rolfe; A DeLucia; R M Strieter; G D Abrams; S L Kunkel; C T Esmon; S K Wrobleski; A M Kadell
Journal:  Thromb Haemost       Date:  1993-02-01       Impact factor: 5.249

10.  Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.

Authors:  T W Wakefield; R M Strieter; C A Wilke; A M Kadell; S K Wrobleski; M D Burdick; R Schmidt; S L Kunkel; L J Greenfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-02       Impact factor: 8.311

View more
  6 in total

1.  Christian Doppler and the influence of his work on modern medicine.

Authors:  Franz Kainberger; Sepp Leodolter
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

2.  Risk factors for venous thromboembolism and evaluation of the modified Caprini score in patients undergoing lung resection.

Authors:  Songping Cui; Shuo Chen; Hui Li; Lihui Ke; Yi Liu; Ruiheng Jiang; Bin Hu; Tong Li; Yang Wang; Jinbai Miao; Wenqian Zhang
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

3.  Early stroke-related deep venous thrombosis: risk factors and influence on outcome.

Authors:  Jan Bembenek; Michal Karlinski; Adam Kobayashi; Anna Czlonkowska
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

4.  Experimental Study of Phlebitis Ointment Administration in Acute Superficial Thrombophlebitis.

Authors:  Guangzong Li; Gerhard Litscher; He Pang; Baozhong Yang; Daniela Litscher; Lu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-24       Impact factor: 2.629

5.  Comparison of pathological clotting using haematological, functional and morphological investigations in HIV-positive and HIV-negative patients with deep vein thrombosis.

Authors:  Brandon S Jackson; Julien Nunes Goncalves; Etheresia Pretorius
Journal:  Retrovirology       Date:  2020-06-22       Impact factor: 4.602

6.  Investigation of the role of infusate properties related to midline catheter failure in an ovine model.

Authors:  Marcia Ryder; Robert A Gunther; Reid A Nishikawa; Marc Stranz; Britt M Meyer; Taylor A Spangler; Albert E Parker; Charles Sylvia
Journal:  Am J Health Syst Pharm       Date:  2020-08-07       Impact factor: 2.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.